first was a staphylococcus albus infection which arose in a primary ventriculoatrial shunt inserted in a 60-year-old patient who had developed hydrocephalus in association with a cystic tumour of the posterior fossa. The second was an Escherichia coli infection which occurred after a revision of the upper end of a ventriculoperitoneal shunt in a 2-year-old child who had hydrocephalus caused by a Dandy-Walker cyst. The third was a Staph albus infection which occurred after revision of the lower end of a ventriculoperitoneal shunt in a 1-year-old child who had presented with non-communicating hydrocephalus at the age of 3 months. The age range of the patients and the number of shunts carried out were as follows: under 1 year, 34; 1 to 10 years, 64; 10 to 20 years, 43; and over 20 years, 59.
Comment
Recent reports suggest that prophylactic antibiotics may prevent shunt infection.' 3Malis4 reported a series of 1732 consecutive major neurosurgical operations in which intraoperative prophylactic tobramycin, vancomycin, and streptomycin were given and in which no postoperative infections occurred.4 Prophylactic antibiotics are not used in our unit, since they are thought to be of minor prophylactic value and give rise to resistant bacteria and consequently infections which may prove difficult to treat. We consider that careful surgical technique is the single most important factor in the prevention of shunt infection. 
Irradiation depresses peripheral lymphocyte counts and has diverse effects on lymphocyte function. These effects may persist for many years.2 There is one reported case of a patient with polymyositis treated successfully with total body irradiation after failure of conventional treatment.3 In our patient the dose of 150 cGy given as total body irradiation produced mild dyspepsia and transient granulocytopenia as the only side effects. In assessing the effect of treatment we employed serial strain-gauge myometric estimations of major muscle groups, a method which in our experience produced reliable and reproducible measurements of muscle strength.4 These data supported the clinical, biochemical, and histological evidence of improvement in muscle inflammation after total body irradiation. Throughout this period there was no change in the doses of oral immunosuppressive drugs.
Radiation-induced immunosuppression, given as total lymphoid irradiation, has recently been used in the treatment of intractable rheumatoid arthritis. Total body irradiation offers advantages over this method in the ease of administration, the low incidence of side effects, and the substantially lower dose. The main long-term hazardcarcinogenesis or leukaemogenesis-should be lower, possibly no more than a lifetime fatal cancer risk of 1 % after 25 years.5
This case provides further evidence that total body irradiation may provide a useful additional form of management in cases of polymyositis resistant to conventional drug treatment, although a lasting effect has not been demonstrated. Effect of nifedipine on histamine reactivity in asthma
The release of mast-cell mediators and the contraction of smooth muscle are associated with influx of calcium ions. Williams et all reported that the calcium antagonist nifedipine given sublingually modified histamine-induced bronchoconstriction in asthma. Our observations, however, show that the calcium antagonist verapamil given by. inhalation does not modify histamine or methacholine bronchoconstriction in asthma.2 We report the effect of 20 mg nifedipine and a matched placebo on histamine reactivity in eight patients with allergic asthma.
Patients, methods, and results
We studied eight patients aged between 17 and 33 years with allergic asthma and reversible airflow obstruction. Sodium cromoglycate and bronchodilators were discontinued for at least 24 hours before each test was carried out. Forced expiratory volume in one second was measured with a water-sealed spirometer (Godart Pulmotest) and values corrected for body temperature, pressure, and saturation. Each subject was then given 20 mg nifedipine or a matched placebo sublingually on a double-blind basis. Pulse rate and blood pressure were recorded at five-minute intervals for 30 minutes. Measurement of forced expiratory volume in one second was repeated at 30 minutes and followed by two-minute inhalations of histamine dihydrochloride through a Wright nebuliser in doubling concentrations from 0-025 to 8 g/l at tidal breathing. After each inhalation forced expiratory volume in one second was recorded at 0-5, one, three, and five minutes and subsequent intervals of two minutes to obtain the lowest value after inhalation. Inhalation of histamine was continued until the forced expiratory volume in one second had fallen by 200o or more. The responses were expressed in terms of the provocative concentration of histamine producing a 20%, fall in forced expiratory volume in one second (PC20ui) and calculated as described previously.2 Results of the study are shown in the table. There was no significant difference in the mean baseline forced expiratory volume in one second before and after nifedipine or a matched placebo. Furthermore, the mean percentage changes in forced expiratory volume in one second and the PC20H for histamine were not significantly altered by nifedipine. Pulse rate and blood pressure changes were also not significant.
Comment
In contrast to the results reported by Williams et al,1 nifedipine did not modify histamine reactivity in the patients we studied. We did not observe the significant changes in blood pressure or pulse rate reported by Millar and Struthers3 in normal subjects with a similar dose of nifedipine. Our observations with verapamil and nifedipine suggest that the effect of calcium antagonists on the bronchial smooth muscle in patients with asthma is minimal. The beneficial effect of verapamil and nifedipine in exercise-induced asthma4 5 is probably on mast-cell degranulation, which is calcium dependent.
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